#FORMAT=WebAnno TSV 3.3
#T_SP=webanno.custom.ConceptLayer|identifier


Text=Predicting development of adolescent drinking behaviour from whole brain structure at 14 years of age Adolescence is a common time for initiation of alcohol use and development of alcohol use disorders.
1-1	0-10	Predicting	_
1-2	11-22	development	_
1-3	23-25	of	_
1-4	26-36	adolescent	_
1-5	37-45	drinking	_
1-6	46-55	behaviour	_
1-7	56-60	from	_
1-8	61-66	whole	_
1-9	67-72	brain	_
1-10	73-82	structure	_
1-11	83-85	at	_
1-12	86-88	14	_
1-13	89-94	years	_
1-14	95-97	of	_
1-15	98-101	age	_
1-16	102-113	Adolescence	_
1-17	114-116	is	_
1-18	117-118	a	_
1-19	119-125	common	_
1-20	126-130	time	_
1-21	131-134	for	_
1-22	135-145	initiation	_
1-23	146-148	of	_
1-24	149-156	alcohol	_
1-25	157-160	use	_
1-26	161-164	and	_
1-27	165-176	development	_
1-28	177-179	of	_
1-29	180-187	alcohol	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseScale
1-30	188-191	use	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseScale
1-31	192-201	disorders	_
1-32	202-203	.	_

Text=The present study investigates neuroanatomical predictors for trajectories of future alcohol use based on a novel voxel-wise whole-brain structural equation modeling framework.
2-1	204-207	The	_
2-2	208-215	present	_
2-3	216-221	study	_
2-4	222-234	investigates	_
2-5	235-250	neuroanatomical	_
2-6	251-261	predictors	_
2-7	262-265	for	_
2-8	266-278	trajectories	_
2-9	279-281	of	_
2-10	282-288	future	_
2-11	289-296	alcohol	_
2-12	297-300	use	_
2-13	301-306	based	_
2-14	307-309	on	_
2-15	310-311	a	_
2-16	312-317	novel	_
2-17	318-328	voxel-wise	_
2-18	329-340	whole-brain	_
2-19	341-351	structural	_
2-20	352-360	equation	_
2-21	361-369	modeling	_
2-22	370-379	framework	_
2-23	380-381	.	_

Text=In 1814 healthy adolescents of the IMAGEN sample, the Alcohol Use Disorder Identification Test (AUDIT) was acquired at three measurement occasions across five years.
3-1	382-384	In	_
3-2	385-389	1814	_
3-3	390-397	healthy	_
3-4	398-409	adolescents	_
3-5	410-412	of	_
3-6	413-416	the	_
3-7	417-423	IMAGEN	http://maven.renci.org/NeuroBridge/neurobridge#Mode
3-8	424-430	sample	http://maven.renci.org/NeuroBridge/neurobridge#Mode
3-9	431-432	,	_
3-10	433-436	the	_
3-11	437-444	Alcohol	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseDisordersIdentificationTest
3-12	445-448	Use	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseDisordersIdentificationTest
3-13	449-457	Disorder	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseDisordersIdentificationTest
3-14	458-472	Identification	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseDisordersIdentificationTest
3-15	473-477	Test	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseDisordersIdentificationTest
3-16	478-479	(	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseDisordersIdentificationTest
3-17	480-485	AUDIT	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseDisordersIdentificationTest
3-18	486-487	)	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseDisordersIdentificationTest
3-19	488-491	was	_
3-20	492-500	acquired	_
3-21	501-503	at	_
3-22	504-509	three	_
3-23	510-521	measurement	_
3-24	522-531	occasions	_
3-25	532-538	across	_
3-26	539-543	five	_
3-27	544-549	years	_
3-28	550-551	.	_

Text=Based on a two-part latent growth curve model, we conducted whole-brain analyses on structural MRI data at age 14, predicting change in alcohol use score over time.
4-1	552-557	Based	_
4-2	558-560	on	_
4-3	561-562	a	_
4-4	563-571	two-part	_
4-5	572-578	latent	_
4-6	579-585	growth	_
4-7	586-591	curve	_
4-8	592-597	model	_
4-9	598-599	,	_
4-10	600-602	we	_
4-11	603-612	conducted	_
4-12	613-624	whole-brain	_
4-13	625-633	analyses	_
4-14	634-636	on	_
4-15	637-647	structural	http://maven.renci.org/NeuroBridge/neurobridge#StructuralImaging
4-16	648-651	MRI	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging
4-17	652-656	data	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging
4-18	657-659	at	_
4-19	660-663	age	_
4-20	664-666	14	_
4-21	667-668	,	_
4-22	669-679	predicting	_
4-23	680-686	change	_
4-24	687-689	in	_
4-25	690-697	alcohol	_
4-26	698-701	use	_
4-27	702-707	score	_
4-28	708-712	over	_
4-29	713-717	time	_
4-30	718-719	.	_

Text=Higher grey-matter volumes in the caudate nucleus and the left cerebellum at age 14 years were predictive of stronger increase in alcohol use score over 5 years.
5-1	720-726	Higher	_
5-2	727-738	grey-matter	_
5-3	739-746	volumes	_
5-4	747-749	in	_
5-5	750-753	the	_
5-6	754-761	caudate	_
5-7	762-769	nucleus	_
5-8	770-773	and	_
5-9	774-777	the	_
5-10	778-782	left	_
5-11	783-793	cerebellum	_
5-12	794-796	at	_
5-13	797-800	age	_
5-14	801-803	14	_
5-15	804-809	years	_
5-16	810-814	were	_
5-17	815-825	predictive	_
5-18	826-828	of	_
5-19	829-837	stronger	_
5-20	838-846	increase	_
5-21	847-849	in	_
5-22	850-857	alcohol	_
5-23	858-861	use	_
5-24	862-867	score	_
5-25	868-872	over	_
5-26	873-874	5	_
5-27	875-880	years	_
5-28	881-882	.	_

Text=The study is the first to demonstrate the feasibility of running separate voxel-wise structural equation models thereby opening new avenues for data analysis in brain imaging.
6-1	883-886	The	_
6-2	887-892	study	_
6-3	893-895	is	_
6-4	896-899	the	_
6-5	900-905	first	_
6-6	906-908	to	_
6-7	909-920	demonstrate	_
6-8	921-924	the	_
6-9	925-936	feasibility	_
6-10	937-939	of	_
6-11	940-947	running	_
6-12	948-956	separate	_
6-13	957-967	voxel-wise	_
6-14	968-978	structural	_
6-15	979-987	equation	_
6-16	988-994	models	_
6-17	995-1002	thereby	_
6-18	1003-1010	opening	_
6-19	1011-1014	new	_
6-20	1015-1022	avenues	_
6-21	1023-1026	for	_
6-22	1027-1031	data	_
6-23	1032-1040	analysis	_
6-24	1041-1043	in	_
6-25	1044-1049	brain	_
6-26	1050-1057	imaging	_
6-27	1058-1059	.	_

Text=eLife digest Puberty is a time of transformation.
7-1	1060-1065	eLife	_
7-2	1066-1072	digest	_
7-3	1073-1080	Puberty	_
7-4	1081-1083	is	_
7-5	1084-1085	a	_
7-6	1086-1090	time	_
7-7	1091-1093	of	_
7-8	1094-1108	transformation	_
7-9	1109-1110	.	_

Text=Physical changes in the body occur alongside changes in personality and behaviour.
8-1	1111-1119	Physical	_
8-2	1120-1127	changes	_
8-3	1128-1130	in	_
8-4	1131-1134	the	_
8-5	1135-1139	body	_
8-6	1140-1145	occur	_
8-7	1146-1155	alongside	_
8-8	1156-1163	changes	_
8-9	1164-1166	in	_
8-10	1167-1178	personality	_
8-11	1179-1182	and	_
8-12	1183-1192	behaviour	_
8-13	1193-1194	.	_

Text=Compared to children, adolescents tend to be risk-takers and novelty-seekers.
9-1	1195-1203	Compared	_
9-2	1204-1206	to	_
9-3	1207-1215	children	_
9-4	1216-1217	,	_
9-5	1218-1229	adolescents	_
9-6	1230-1234	tend	_
9-7	1235-1237	to	_
9-8	1238-1240	be	_
9-9	1241-1252	risk-takers	_
9-10	1253-1256	and	_
9-11	1257-1272	novelty-seekers	_
9-12	1273-1274	.	_

Text=They crave new sensations and experiences, as well as social interaction with their peers.
10-1	1275-1279	They	_
10-2	1280-1285	crave	_
10-3	1286-1289	new	_
10-4	1290-1300	sensations	_
10-5	1301-1304	and	_
10-6	1305-1316	experiences	_
10-7	1317-1318	,	_
10-8	1319-1321	as	_
10-9	1322-1326	well	_
10-10	1327-1329	as	_
10-11	1330-1336	social	_
10-12	1337-1348	interaction	_
10-13	1349-1353	with	_
10-14	1354-1359	their	_
10-15	1360-1365	peers	_
10-16	1366-1367	.	_

Text=It is around puberty that many people try alcohol for the first time.
11-1	1368-1370	It	_
11-2	1371-1373	is	_
11-3	1374-1380	around	_
11-4	1381-1388	puberty	_
11-5	1389-1393	that	_
11-6	1394-1398	many	_
11-7	1399-1405	people	_
11-8	1406-1409	try	_
11-9	1410-1417	alcohol	_
11-10	1418-1421	for	_
11-11	1422-1425	the	_
11-12	1426-1431	first	_
11-13	1432-1436	time	_
11-14	1437-1438	.	_

Text=But it is not clear why people differ in their drinking habits, and why a small minority of young adults go on to become dependent on alcohol.
12-1	1439-1442	But	_
12-2	1443-1445	it	_
12-3	1446-1448	is	_
12-4	1449-1452	not	_
12-5	1453-1458	clear	_
12-6	1459-1462	why	_
12-7	1463-1469	people	_
12-8	1470-1476	differ	_
12-9	1477-1479	in	_
12-10	1480-1485	their	_
12-11	1486-1494	drinking	_
12-12	1495-1501	habits	_
12-13	1502-1503	,	_
12-14	1504-1507	and	_
12-15	1508-1511	why	_
12-16	1512-1513	a	_
12-17	1514-1519	small	_
12-18	1520-1528	minority	_
12-19	1529-1531	of	_
12-20	1532-1537	young	_
12-21	1538-1544	adults	_
12-22	1545-1547	go	_
12-23	1548-1550	on	_
12-24	1551-1553	to	_
12-25	1554-1560	become	_
12-26	1561-1570	dependent	_
12-27	1571-1573	on	_
12-28	1574-1581	alcohol	_
12-29	1582-1583	.	_

Text=Part of the answer may lie in changes in the brain.
13-1	1584-1588	Part	_
13-2	1589-1591	of	_
13-3	1592-1595	the	_
13-4	1596-1602	answer	_
13-5	1603-1606	may	_
13-6	1607-1610	lie	_
13-7	1611-1613	in	_
13-8	1614-1621	changes	_
13-9	1622-1624	in	_
13-10	1625-1628	the	_
13-11	1629-1634	brain	_
13-12	1635-1636	.	_

Text=Differences in the size and structure of brain regions contribute to differences in behaviour between individuals.
14-1	1637-1648	Differences	_
14-2	1649-1651	in	_
14-3	1652-1655	the	_
14-4	1656-1660	size	_
14-5	1661-1664	and	_
14-6	1665-1674	structure	_
14-7	1675-1677	of	_
14-8	1678-1683	brain	_
14-9	1684-1691	regions	_
14-10	1692-1702	contribute	_
14-11	1703-1705	to	_
14-12	1706-1717	differences	_
14-13	1718-1720	in	_
14-14	1721-1730	behaviour	_
14-15	1731-1738	between	_
14-16	1739-1750	individuals	_
14-17	1751-1752	.	_

Text=During adolescence, the brain undergoes extensive re-modelling.
15-1	1753-1759	During	_
15-2	1760-1771	adolescence	_
15-3	1772-1773	,	_
15-4	1774-1777	the	_
15-5	1778-1783	brain	_
15-6	1784-1793	undergoes	_
15-7	1794-1803	extensive	_
15-8	1804-1816	re-modelling	_
15-9	1817-1818	.	_

Text=It forms new connections, while also pruning away connections that are unused.
16-1	1819-1821	It	_
16-2	1822-1827	forms	_
16-3	1828-1831	new	_
16-4	1832-1843	connections	_
16-5	1844-1845	,	_
16-6	1846-1851	while	_
16-7	1852-1856	also	_
16-8	1857-1864	pruning	_
16-9	1865-1869	away	_
16-10	1870-1881	connections	_
16-11	1882-1886	that	_
16-12	1887-1890	are	_
16-13	1891-1897	unused	_
16-14	1898-1899	.	_

Text=Could differences in brain structure at puberty lead to differences in alcohol consumption in early adulthood?
17-1	1900-1905	Could	_
17-2	1906-1917	differences	_
17-3	1918-1920	in	_
17-4	1921-1926	brain	_
17-5	1927-1936	structure	_
17-6	1937-1939	at	_
17-7	1940-1947	puberty	_
17-8	1948-1952	lead	_
17-9	1953-1955	to	_
17-10	1956-1967	differences	_
17-11	1968-1970	in	_
17-12	1971-1978	alcohol	_
17-13	1979-1990	consumption	_
17-14	1991-1993	in	_
17-15	1994-1999	early	_
17-16	2000-2009	adulthood	_
17-17	2010-2011	?	_

Text=Kühn et al.
18-1	2012-2016	Kühn	_
18-2	2017-2019	et	_
18-3	2020-2022	al	_
18-4	2023-2024	.	_

Text=scanned the brains of about 1,800 healthy adolescents at the age of 14 and then again at 19 (within the context of the IMAGEN study).
19-1	2025-2032	scanned	_
19-2	2033-2036	the	_
19-3	2037-2043	brains	_
19-4	2044-2046	of	_
19-5	2047-2052	about	_
19-6	2053-2058	1,800	_
19-7	2059-2066	healthy	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
19-8	2067-2078	adolescents	_
19-9	2079-2081	at	_
19-10	2082-2085	the	_
19-11	2086-2089	age	_
19-12	2090-2092	of	_
19-13	2093-2095	14	_
19-14	2096-2099	and	_
19-15	2100-2104	then	_
19-16	2105-2110	again	_
19-17	2111-2113	at	_
19-18	2114-2116	19	_
19-19	2117-2118	(	_
19-20	2119-2125	within	_
19-21	2126-2129	the	_
19-22	2130-2137	context	_
19-23	2138-2140	of	_
19-24	2141-2144	the	_
19-25	2145-2151	IMAGEN	_
19-26	2152-2157	study	_
19-27	2158-2159	)	_
19-28	2160-2161	.	_

Text=At three time points, the teenagers also filled in questionnaires about their use of alcohol.
20-1	2162-2164	At	_
20-2	2165-2170	three	_
20-3	2171-2175	time	_
20-4	2176-2182	points	_
20-5	2183-2184	,	_
20-6	2185-2188	the	_
20-7	2189-2198	teenagers	_
20-8	2199-2203	also	_
20-9	2204-2210	filled	_
20-10	2211-2213	in	_
20-11	2214-2228	questionnaires	_
20-12	2229-2234	about	_
20-13	2235-2240	their	_
20-14	2241-2244	use	_
20-15	2245-2247	of	_
20-16	2248-2255	alcohol	_
20-17	2256-2257	.	_

Text=Two areas of the brain – the caudate nucleus and the left cerebellum – were larger at age 14 in teenagers who would increase their alcohol consumption by age 19.
21-1	2258-2261	Two	_
21-2	2262-2267	areas	_
21-3	2268-2270	of	_
21-4	2271-2274	the	_
21-5	2275-2280	brain	_
21-6	2281-2282	–	_
21-7	2283-2286	the	_
21-8	2287-2294	caudate	_
21-9	2295-2302	nucleus	_
21-10	2303-2306	and	_
21-11	2307-2310	the	_
21-12	2311-2315	left	_
21-13	2316-2326	cerebellum	_
21-14	2327-2328	–	_
21-15	2329-2333	were	_
21-16	2334-2340	larger	_
21-17	2341-2343	at	_
21-18	2344-2347	age	_
21-19	2348-2350	14	_
21-20	2351-2353	in	_
21-21	2354-2363	teenagers	_
21-22	2364-2367	who	_
21-23	2368-2373	would	_
21-24	2374-2382	increase	_
21-25	2383-2388	their	_
21-26	2389-2396	alcohol	_
21-27	2397-2408	consumption	_
21-28	2409-2411	by	_
21-29	2412-2415	age	_
21-30	2416-2418	19	_
21-31	2419-2420	.	_

Text=The larger the areas at age 14, the bigger the increase in alcohol consumption over time.
22-1	2421-2424	The	_
22-2	2425-2431	larger	_
22-3	2432-2435	the	_
22-4	2436-2441	areas	_
22-5	2442-2444	at	_
22-6	2445-2448	age	_
22-7	2449-2451	14	_
22-8	2452-2453	,	_
22-9	2454-2457	the	_
22-10	2458-2464	bigger	_
22-11	2465-2468	the	_
22-12	2469-2477	increase	_
22-13	2478-2480	in	_
22-14	2481-2488	alcohol	_
22-15	2489-2500	consumption	_
22-16	2501-2505	over	_
22-17	2506-2510	time	_
22-18	2511-2512	.	_

Text=Notably, there was no relationship between the size of either brain area at the age of 14 and how much alcohol the individuals drank at the same age.
23-1	2513-2520	Notably	_
23-2	2521-2522	,	_
23-3	2523-2528	there	_
23-4	2529-2532	was	_
23-5	2533-2535	no	_
23-6	2536-2548	relationship	_
23-7	2549-2556	between	_
23-8	2557-2560	the	_
23-9	2561-2565	size	_
23-10	2566-2568	of	_
23-11	2569-2575	either	_
23-12	2576-2581	brain	_
23-13	2582-2586	area	_
23-14	2587-2589	at	_
23-15	2590-2593	the	_
23-16	2594-2597	age	_
23-17	2598-2600	of	_
23-18	2601-2603	14	_
23-19	2604-2607	and	_
23-20	2608-2611	how	_
23-21	2612-2616	much	_
23-22	2617-2624	alcohol	_
23-23	2625-2628	the	_
23-24	2629-2640	individuals	_
23-25	2641-2646	drank	_
23-26	2647-2649	at	_
23-27	2650-2653	the	_
23-28	2654-2658	same	_
23-29	2659-2662	age	_
23-30	2663-2664	.	_

Text=These results may help us to understand why some young adults develop harmful drinking habits, whereas most do not.
24-1	2665-2670	These	_
24-2	2671-2678	results	_
24-3	2679-2682	may	_
24-4	2683-2687	help	_
24-5	2688-2690	us	_
24-6	2691-2693	to	_
24-7	2694-2704	understand	_
24-8	2705-2708	why	_
24-9	2709-2713	some	_
24-10	2714-2719	young	_
24-11	2720-2726	adults	_
24-12	2727-2734	develop	_
24-13	2735-2742	harmful	_
24-14	2743-2751	drinking	_
24-15	2752-2758	habits	_
24-16	2759-2760	,	_
24-17	2761-2768	whereas	_
24-18	2769-2773	most	_
24-19	2774-2776	do	_
24-20	2777-2780	not	_
24-21	2781-2782	.	_

Text=The findings are part of a large and complex picture.
25-1	2783-2786	The	_
25-2	2787-2795	findings	_
25-3	2796-2799	are	_
25-4	2800-2804	part	_
25-5	2805-2807	of	_
25-6	2808-2809	a	_
25-7	2810-2815	large	_
25-8	2816-2819	and	_
25-9	2820-2827	complex	_
25-10	2828-2835	picture	_
25-11	2836-2837	.	_

Text=Other factors, such as social influences, also shape alcohol consumption.
26-1	2838-2843	Other	_
26-2	2844-2851	factors	_
26-3	2852-2853	,	_
26-4	2854-2858	such	_
26-5	2859-2861	as	_
26-6	2862-2868	social	_
26-7	2869-2879	influences	_
26-8	2880-2881	,	_
26-9	2882-2886	also	_
26-10	2887-2892	shape	_
26-11	2893-2900	alcohol	_
26-12	2901-2912	consumption	_
26-13	2913-2914	.	_

Text=However, the findings of Kühn et al.
27-1	2915-2922	However	_
27-2	2923-2924	,	_
27-3	2925-2928	the	_
27-4	2929-2937	findings	_
27-5	2938-2940	of	_
27-6	2941-2945	Kühn	_
27-7	2946-2948	et	_
27-8	2949-2951	al	_
27-9	2952-2953	.	_

Text=suggest that differences in brain structure may make some individuals more likely to increase how much alcohol they drink than others.
28-1	2954-2961	suggest	_
28-2	2962-2966	that	_
28-3	2967-2978	differences	_
28-4	2979-2981	in	_
28-5	2982-2987	brain	_
28-6	2988-2997	structure	_
28-7	2998-3001	may	_
28-8	3002-3006	make	_
28-9	3007-3011	some	_
28-10	3012-3023	individuals	_
28-11	3024-3028	more	_
28-12	3029-3035	likely	_
28-13	3036-3038	to	_
28-14	3039-3047	increase	_
28-15	3048-3051	how	_
28-16	3052-3056	much	_
28-17	3057-3064	alcohol	_
28-18	3065-3069	they	_
28-19	3070-3075	drink	_
28-20	3076-3080	than	_
28-21	3081-3087	others	_
28-22	3088-3089	.	_

Text=Understanding these biological differences could help researchers to develop measures to prevent addiction in young adults.
29-1	3090-3103	Understanding	_
29-2	3104-3109	these	_
29-3	3110-3120	biological	_
29-4	3121-3132	differences	_
29-5	3133-3138	could	_
29-6	3139-3143	help	_
29-7	3144-3155	researchers	_
29-8	3156-3158	to	_
29-9	3159-3166	develop	_
29-10	3167-3175	measures	_
29-11	3176-3178	to	_
29-12	3179-3186	prevent	_
29-13	3187-3196	addiction	_
29-14	3197-3199	in	_
29-15	3200-3205	young	_
29-16	3206-3212	adults	_
29-17	3213-3214	.	_

Text=Materials and methods Participants We used data of 1794 healthy 14-year-old adolescents (mean age = 14.4, SD = 0.45 years; 54% males) who were recruited within the scope of the IMAGEN project, a European multi-centre genetic-neuroimaging study in adolescence.
30-1	3215-3224	Materials	http://maven.renci.org/NeuroBridge/neurobridge#StudyMethod
30-2	3225-3228	and	http://maven.renci.org/NeuroBridge/neurobridge#StudyMethod
30-3	3229-3236	methods	http://maven.renci.org/NeuroBridge/neurobridge#StudyMethod
30-4	3237-3249	Participants	_
30-5	3250-3252	We	_
30-6	3253-3257	used	_
30-7	3258-3262	data	_
30-8	3263-3265	of	_
30-9	3266-3270	1794	_
30-10	3271-3278	healthy	_
30-11	3279-3290	14-year-old	_
30-12	3291-3302	adolescents	http://maven.renci.org/NeuroBridge/neurobridge#Cholesterol
30-13	3303-3304	(	_
30-14	3305-3309	mean	_
30-15	3310-3313	age	_
30-16	3314-3315	=	_
30-17	3316-3320	14.4	_
30-18	3321-3322	,	_
30-19	3323-3325	SD	_
30-20	3326-3327	=	_
30-21	3328-3332	0.45	_
30-22	3333-3338	years	_
30-23	3339-3340	;	_
30-24	3341-3343	54	_
30-25	3344-3345	%	_
30-26	3346-3351	males	_
30-27	3352-3353	)	_
30-28	3354-3357	who	_
30-29	3358-3362	were	_
30-30	3363-3372	recruited	_
30-31	3373-3379	within	_
30-32	3380-3383	the	_
30-33	3384-3389	scope	_
30-34	3390-3392	of	_
30-35	3393-3396	the	_
30-36	3397-3403	IMAGEN	_
30-37	3404-3411	project	_
30-38	3412-3413	,	_
30-39	3414-3415	a	_
30-40	3416-3424	European	_
30-41	3425-3437	multi-centre	_
30-42	3438-3458	genetic-neuroimaging	_
30-43	3459-3464	study	_
30-44	3465-3467	in	_
30-45	3468-3479	adolescence	_
30-46	3480-3481	.	_

Text=The selection of the participants was based on the fact that structural imaging data at age of 14 years was present.
31-1	3482-3485	The	_
31-2	3486-3495	selection	_
31-3	3496-3498	of	_
31-4	3499-3502	the	_
31-5	3503-3515	participants	_
31-6	3516-3519	was	_
31-7	3520-3525	based	_
31-8	3526-3528	on	_
31-9	3529-3532	the	_
31-10	3533-3537	fact	_
31-11	3538-3542	that	_
31-12	3543-3553	structural	_
31-13	3554-3561	imaging	_
31-14	3562-3566	data	_
31-15	3567-3569	at	_
31-16	3570-3573	age	_
31-17	3574-3576	of	_
31-18	3577-3579	14	_
31-19	3580-3585	years	_
31-20	3586-3589	was	_
31-21	3590-3597	present	_
31-22	3598-3599	.	_

Text=At the time of analyses reported here (age 14 years), retest data at age 16–17 years was present for 1439 participants (mean age = 16.6, SD = 0.64 years; 55% males) and at age 19 years for 1284 participants (mean age = 19.0, SD = 0.77 years; 53% males).
32-1	3600-3602	At	_
32-2	3603-3606	the	_
32-3	3607-3611	time	_
32-4	3612-3614	of	_
32-5	3615-3623	analyses	_
32-6	3624-3632	reported	_
32-7	3633-3637	here	_
32-8	3638-3639	(	_
32-9	3640-3643	age	_
32-10	3644-3646	14	_
32-11	3647-3652	years	_
32-12	3653-3654	)	_
32-13	3655-3656	,	_
32-14	3657-3663	retest	_
32-15	3664-3668	data	_
32-16	3669-3671	at	_
32-17	3672-3675	age	_
32-18	3676-3681	16–17	_
32-19	3682-3687	years	_
32-20	3688-3691	was	_
32-21	3692-3699	present	_
32-22	3700-3703	for	_
32-23	3704-3708	1439	_
32-24	3709-3721	participants	_
32-25	3722-3723	(	_
32-26	3724-3728	mean	_
32-27	3729-3732	age	_
32-28	3733-3734	=	_
32-29	3735-3739	16.6	_
32-30	3740-3741	,	_
32-31	3742-3744	SD	_
32-32	3745-3746	=	_
32-33	3747-3751	0.64	_
32-34	3752-3757	years	_
32-35	3758-3759	;	_
32-36	3760-3762	55	_
32-37	3763-3764	%	_
32-38	3765-3770	males	_
32-39	3771-3772	)	_
32-40	3773-3776	and	_
32-41	3777-3779	at	_
32-42	3780-3783	age	_
32-43	3784-3786	19	_
32-44	3787-3792	years	_
32-45	3793-3796	for	_
32-46	3797-3801	1284	_
32-47	3802-3814	participants	_
32-48	3815-3816	(	_
32-49	3817-3821	mean	_
32-50	3822-3825	age	_
32-51	3826-3827	=	_
32-52	3828-3832	19.0	_
32-53	3833-3834	,	_
32-54	3835-3837	SD	_
32-55	3838-3839	=	_
32-56	3840-3844	0.77	_
32-57	3845-3850	years	_
32-58	3851-3852	;	_
32-59	3853-3855	53	_
32-60	3856-3857	%	_
32-61	3858-3863	males	_
32-62	3864-3865	)	_
32-63	3866-3867	.	_

Text=Written informed consent was obtained from all participants as well as from their legal guardians.
33-1	3868-3875	Written	_
33-2	3876-3884	informed	_
33-3	3885-3892	consent	_
33-4	3893-3896	was	_
33-5	3897-3905	obtained	_
33-6	3906-3910	from	_
33-7	3911-3914	all	_
33-8	3915-3927	participants	_
33-9	3928-3930	as	_
33-10	3931-3935	well	_
33-11	3936-3938	as	_
33-12	3939-3943	from	_
33-13	3944-3949	their	_
33-14	3950-3955	legal	_
33-15	3956-3965	guardians	_
33-16	3966-3967	.	_

Text=The adolescents were recruited from secondary schools.
34-1	3968-3971	The	_
34-2	3972-3983	adolescents	_
34-3	3984-3988	were	_
34-4	3989-3998	recruited	_
34-5	3999-4003	from	_
34-6	4004-4013	secondary	_
34-7	4014-4021	schools	_
34-8	4022-4023	.	_

Text=The study was approved by all local ethics committees separately (in Germany this was accomplished by the medical ethics committee of the University of Heidelberg, reference number: 2007-024N-MA) and approved by the head teachers of the respective schools.
35-1	4024-4027	The	_
35-2	4028-4033	study	_
35-3	4034-4037	was	_
35-4	4038-4046	approved	_
35-5	4047-4049	by	_
35-6	4050-4053	all	_
35-7	4054-4059	local	_
35-8	4060-4066	ethics	_
35-9	4067-4077	committees	_
35-10	4078-4088	separately	_
35-11	4089-4090	(	_
35-12	4091-4093	in	_
35-13	4094-4101	Germany	_
35-14	4102-4106	this	_
35-15	4107-4110	was	_
35-16	4111-4123	accomplished	_
35-17	4124-4126	by	_
35-18	4127-4130	the	_
35-19	4131-4138	medical	_
35-20	4139-4145	ethics	_
35-21	4146-4155	committee	_
35-22	4156-4158	of	_
35-23	4159-4162	the	_
35-24	4163-4173	University	_
35-25	4174-4176	of	_
35-26	4177-4187	Heidelberg	_
35-27	4188-4189	,	_
35-28	4190-4199	reference	_
35-29	4200-4206	number	_
35-30	4207-4208	:	_
35-31	4209-4221	2007-024N-MA	_
35-32	4222-4223	)	_
35-33	4224-4227	and	_
35-34	4228-4236	approved	_
35-35	4237-4239	by	_
35-36	4240-4243	the	_
35-37	4244-4248	head	_
35-38	4249-4257	teachers	_
35-39	4258-4260	of	_
35-40	4261-4264	the	_
35-41	4265-4275	respective	_
35-42	4276-4283	schools	_
35-43	4284-4285	.	_

Text=Participants with a medical condition or neurological disorders were excluded.
36-1	4286-4298	Participants	_
36-2	4299-4303	with	_
36-3	4304-4305	a	_
36-4	4306-4313	medical	_
36-5	4314-4323	condition	_
36-6	4324-4326	or	_
36-7	4327-4339	neurological	_
36-8	4340-4349	disorders	_
36-9	4350-4354	were	_
36-10	4355-4363	excluded	_
36-11	4364-4365	.	_

Text=All participating subjects were assessed by means of self-rating and two external ratings (by their parents and a psychiatrist specialized in pediatrics) based on ICD-10 as well as DSM-IV (The Development and Well-Being Assessment Interview, DAWBA).
37-1	4366-4369	All	_
37-2	4370-4383	participating	_
37-3	4384-4392	subjects	_
37-4	4393-4397	were	_
37-5	4398-4406	assessed	_
37-6	4407-4409	by	_
37-7	4410-4415	means	_
37-8	4416-4418	of	_
37-9	4419-4430	self-rating	_
37-10	4431-4434	and	_
37-11	4435-4438	two	_
37-12	4439-4447	external	_
37-13	4448-4455	ratings	_
37-14	4456-4457	(	_
37-15	4458-4460	by	_
37-16	4461-4466	their	_
37-17	4467-4474	parents	_
37-18	4475-4478	and	_
37-19	4479-4480	a	_
37-20	4481-4493	psychiatrist	_
37-21	4494-4505	specialized	_
37-22	4506-4508	in	_
37-23	4509-4519	pediatrics	_
37-24	4520-4521	)	_
37-25	4522-4527	based	_
37-26	4528-4530	on	_
37-27	4531-4537	ICD-10	_
37-28	4538-4540	as	_
37-29	4541-4545	well	_
37-30	4546-4548	as	_
37-31	4549-4555	DSM-IV	_
37-32	4556-4557	(	_
37-33	4558-4561	The	_
37-34	4562-4573	Development	_
37-35	4574-4577	and	http://maven.renci.org/NeuroBridge/neurobridge#PhysicalMeasurement
37-36	4578-4588	Well-Being	_
37-37	4589-4599	Assessment	_
37-38	4600-4609	Interview	_
37-39	4610-4611	,	_
37-40	4612-4617	DAWBA	_
37-41	4618-4619	)	_
37-42	4620-4621	.	_

Text=Questionnaire We administered the Alcohol Use Disorder Identification Test (AUDIT,) at Baseline (age 14 years), Follow-up 1 (age 16–17 years) and Follow-up 2 (age 19 years) to identify alcohol use.
38-1	4622-4635	Questionnaire	_
38-2	4636-4638	We	_
38-3	4639-4651	administered	_
38-4	4652-4655	the	_
38-5	4656-4663	Alcohol	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseDisordersIdentificationTest
38-6	4664-4667	Use	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseDisordersIdentificationTest
38-7	4668-4676	Disorder	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseDisordersIdentificationTest
38-8	4677-4691	Identification	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseDisordersIdentificationTest
38-9	4692-4696	Test	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseDisordersIdentificationTest
38-10	4697-4698	(	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseDisordersIdentificationTest
38-11	4699-4704	AUDIT	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseDisordersIdentificationTest
38-12	4705-4706	,	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseDisordersIdentificationTest
38-13	4707-4708	)	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseDisordersIdentificationTest
38-14	4709-4711	at	_
38-15	4712-4720	Baseline	_
38-16	4721-4722	(	_
38-17	4723-4726	age	_
38-18	4727-4729	14	_
38-19	4730-4735	years	_
38-20	4736-4737	)	_
38-21	4738-4739	,	_
38-22	4740-4749	Follow-up	_
38-23	4750-4751	1	_
38-24	4752-4753	(	_
38-25	4754-4757	age	_
38-26	4758-4763	16–17	_
38-27	4764-4769	years	_
38-28	4770-4771	)	_
38-29	4772-4775	and	_
38-30	4776-4785	Follow-up	_
38-31	4786-4787	2	_
38-32	4788-4789	(	_
38-33	4790-4793	age	_
38-34	4794-4796	19	_
38-35	4797-4802	years	_
38-36	4803-4804	)	_
38-37	4805-4807	to	_
38-38	4808-4816	identify	_
38-39	4817-4824	alcohol	_
38-40	4825-4828	use	_
38-41	4829-4830	.	_

Text=We computed the total score by adding the scores of all 10 items.
39-1	4831-4833	We	_
39-2	4834-4842	computed	_
39-3	4843-4846	the	_
39-4	4847-4852	total	_
39-5	4853-4858	score	_
39-6	4859-4861	by	_
39-7	4862-4868	adding	_
39-8	4869-4872	the	_
39-9	4873-4879	scores	_
39-10	4880-4882	of	_
39-11	4883-4886	all	_
39-12	4887-4889	10	_
39-13	4890-4895	items	_
39-14	4896-4897	.	_

Text=Scanning procedure Structural MRI was performed on 3 Tesla scanners from three manufacturers (Siemens: five sites; Philips: two sites; and General Electric: two sites).
40-1	4898-4906	Scanning	_
40-2	4907-4916	procedure	_
40-3	4917-4927	Structural	http://maven.renci.org/NeuroBridge/neurobridge#StructuralImaging
40-4	4928-4931	MRI	http://maven.renci.org/NeuroBridge/neurobridge#StructuralImaging
40-5	4932-4935	was	_
40-6	4936-4945	performed	_
40-7	4946-4948	on	_
40-8	4949-4950	3	_
40-9	4951-4956	Tesla	http://maven.renci.org/NeuroBridge/neurobridge#BackTaskTest
40-10	4957-4965	scanners	_
40-11	4966-4970	from	_
40-12	4971-4976	three	_
40-13	4977-4990	manufacturers	_
40-14	4991-4992	(	_
40-15	4993-5000	Siemens	_
40-16	5001-5002	:	_
40-17	5003-5007	five	_
40-18	5008-5013	sites	_
40-19	5014-5015	;	_
40-20	5016-5023	Philips	_
40-21	5024-5025	:	_
40-22	5026-5029	two	_
40-23	5030-5035	sites	_
40-24	5036-5037	;	_
40-25	5038-5041	and	_
40-26	5042-5049	General	_
40-27	5050-5058	Electric	_
40-28	5059-5060	:	_
40-29	5061-5064	two	_
40-30	5065-5070	sites	_
40-31	5071-5072	)	_
40-32	5073-5074	.	_

Text=The details of the entire MR protocol are described elsewhere.
41-1	5075-5078	The	_
41-2	5079-5086	details	_
41-3	5087-5089	of	_
41-4	5090-5093	the	_
41-5	5094-5100	entire	_
41-6	5101-5103	MR	_
41-7	5104-5112	protocol	_
41-8	5113-5116	are	_
41-9	5117-5126	described	_
41-10	5127-5136	elsewhere	_
41-11	5137-5138	.	_

Text=In this study, we used the T1-weighted images.
42-1	5139-5141	In	_
42-2	5142-5146	this	_
42-3	5147-5152	study	_
42-4	5153-5154	,	_
42-5	5155-5157	we	_
42-6	5158-5162	used	_
42-7	5163-5166	the	_
42-8	5167-5178	T1-weighted	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
42-9	5179-5185	images	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
42-10	5186-5187	.	_

Text=These high-resolution anatomical MRIs were obtained using a three-dimensional magnetization prepared gradient-echo (MPRAGE) sequence based on the ADNI protocol (http: //adni.loni.usc.edu/methods/documents/mri-protocols/; modified for the IMAGEN study to give a 1.1 × 1.1 × 1.1 mm3 voxel size).
43-1	5188-5193	These	_
43-2	5194-5209	high-resolution	http://maven.renci.org/NeuroBridge/neurobridge#HighRisk
43-3	5210-5220	anatomical	http://maven.renci.org/NeuroBridge/neurobridge#HighRisk
43-4	5221-5225	MRIs	http://maven.renci.org/NeuroBridge/neurobridge#HighRisk
43-5	5226-5230	were	_
43-6	5231-5239	obtained	_
43-7	5240-5245	using	_
43-8	5246-5247	a	_
43-9	5248-5265	three-dimensional	_
43-10	5266-5279	magnetization	_
43-11	5280-5288	prepared	_
43-12	5289-5302	gradient-echo	http://maven.renci.org/NeuroBridge/neurobridge#Radiograph
43-13	5303-5304	(	http://maven.renci.org/NeuroBridge/neurobridge#Radiograph
43-14	5305-5311	MPRAGE	http://maven.renci.org/NeuroBridge/neurobridge#Radiograph
43-15	5312-5313	)	http://maven.renci.org/NeuroBridge/neurobridge#Radiograph
43-16	5314-5322	sequence	_
43-17	5323-5328	based	_
43-18	5329-5331	on	_
43-19	5332-5335	the	_
43-20	5336-5340	ADNI	_
43-21	5341-5349	protocol	_
43-22	5350-5351	(	_
43-23	5352-5356	http	_
43-24	5357-5358	:	_
43-25	5359-5411	//adni.loni.usc.edu/methods/documents/mri-protocols/	_
43-26	5412-5413	;	_
43-27	5414-5422	modified	_
43-28	5423-5426	for	_
43-29	5427-5430	the	_
43-30	5431-5437	IMAGEN	_
43-31	5438-5443	study	_
43-32	5444-5446	to	_
43-33	5447-5451	give	_
43-34	5452-5453	a	_
43-35	5454-5457	1.1	_
43-36	5458-5459	×	_
43-37	5460-5463	1.1	_
43-38	5464-5465	×	_
43-39	5466-5469	1.1	_
43-40	5470-5473	mm3	_
43-41	5474-5479	voxel	_
43-42	5480-5484	size	_
43-43	5485-5486	)	_
43-44	5487-5488	.	_

Text=Voxel-based morphometry For the present report, structural MR data of 2072 adolescents were available.
44-1	5489-5500	Voxel-based	_
44-2	5501-5512	morphometry	_
44-3	5513-5516	For	_
44-4	5517-5520	the	_
44-5	5521-5528	present	_
44-6	5529-5535	report	_
44-7	5536-5537	,	_
44-8	5538-5548	structural	http://maven.renci.org/NeuroBridge/neurobridge#StructuralImaging
44-9	5549-5551	MR	http://maven.renci.org/NeuroBridge/neurobridge#StructuralImaging
44-10	5552-5556	data	_
44-11	5557-5559	of	_
44-12	5560-5564	2072	_
44-13	5565-5576	adolescents	_
44-14	5577-5581	were	_
44-15	5582-5591	available	_
44-16	5592-5593	.	_

Text=We excluded all participants where the image quality was suboptimal, most likely due to movement.
45-1	5594-5596	We	_
45-2	5597-5605	excluded	_
45-3	5606-5609	all	_
45-4	5610-5622	participants	_
45-5	5623-5628	where	_
45-6	5629-5632	the	_
45-7	5633-5638	image	_
45-8	5639-5646	quality	_
45-9	5647-5650	was	_
45-10	5651-5661	suboptimal	_
45-11	5662-5663	,	_
45-12	5664-5668	most	_
45-13	5669-5675	likely	_
45-14	5676-5679	due	_
45-15	5680-5682	to	_
45-16	5683-5691	movement	_
45-17	5692-5693	.	_

Text=The visual quality control was carried out by 10 independent raters.
46-1	5694-5697	The	_
46-2	5698-5704	visual	_
46-3	5705-5712	quality	_
46-4	5713-5720	control	_
46-5	5721-5724	was	_
46-6	5725-5732	carried	_
46-7	5733-5736	out	_
46-8	5737-5739	by	_
46-9	5740-5742	10	_
46-10	5743-5754	independent	_
46-11	5755-5761	raters	_
46-12	5762-5763	.	_

Text=Structural data acquired at age 14 years was preprocessed by means of the VBM8 toolbox (http: //dbm.neuro.uni-jena.de/vbm.html) and SPM8 (http: //www.fil.ion.ucl.ac.uk/spm) with default parameters.
47-1	5764-5774	Structural	_
47-2	5775-5779	data	_
47-3	5780-5788	acquired	_
47-4	5789-5791	at	_
47-5	5792-5795	age	_
47-6	5796-5798	14	_
47-7	5799-5804	years	_
47-8	5805-5808	was	_
47-9	5809-5821	preprocessed	_
47-10	5822-5824	by	_
47-11	5825-5830	means	_
47-12	5831-5833	of	_
47-13	5834-5837	the	_
47-14	5838-5842	VBM8	_
47-15	5843-5850	toolbox	_
47-16	5851-5852	(	_
47-17	5853-5857	http	_
47-18	5858-5859	:	_
47-19	5860-5892	//dbm.neuro.uni-jena.de/vbm.html	_
47-20	5893-5894	)	_
47-21	5895-5898	and	_
47-22	5899-5903	SPM8	_
47-23	5904-5905	(	_
47-24	5906-5910	http	_
47-25	5911-5912	:	_
47-26	5913-5940	//www.fil.ion.ucl.ac.uk/spm	_
47-27	5941-5942	)	_
47-28	5943-5947	with	_
47-29	5948-5955	default	_
47-30	5956-5966	parameters	_
47-31	5967-5968	.	_

Text=The VBM8 toolbox involves bias correction, tissue classification and affine registration.
48-1	5969-5972	The	_
48-2	5973-5977	VBM8	_
48-3	5978-5985	toolbox	_
48-4	5986-5994	involves	_
48-5	5995-5999	bias	_
48-6	6000-6010	correction	_
48-7	6011-6012	,	_
48-8	6013-6019	tissue	_
48-9	6020-6034	classification	_
48-10	6035-6038	and	_
48-11	6039-6045	affine	_
48-12	6046-6058	registration	_
48-13	6059-6060	.	_

Text=The affine registered grey matter (GM) and white matter (WM) segmentations were used to build a customized DARTEL (diffeomorphic anatomical registration through exponentiated lie algebra) template.
49-1	6061-6064	The	_
49-2	6065-6071	affine	_
49-3	6072-6082	registered	_
49-4	6083-6087	grey	_
49-5	6088-6094	matter	_
49-6	6095-6096	(	_
49-7	6097-6099	GM	_
49-8	6100-6101	)	_
49-9	6102-6105	and	_
49-10	6106-6111	white	_
49-11	6112-6118	matter	_
49-12	6119-6120	(	_
49-13	6121-6123	WM	_
49-14	6124-6125	)	_
49-15	6126-6139	segmentations	_
49-16	6140-6144	were	_
49-17	6145-6149	used	_
49-18	6150-6152	to	_
49-19	6153-6158	build	_
49-20	6159-6160	a	_
49-21	6161-6171	customized	_
49-22	6172-6178	DARTEL	_
49-23	6179-6180	(	_
49-24	6181-6194	diffeomorphic	_
49-25	6195-6205	anatomical	_
49-26	6206-6218	registration	_
49-27	6219-6226	through	_
49-28	6227-6240	exponentiated	_
49-29	6241-6244	lie	_
49-30	6245-6252	algebra	_
49-31	6253-6254	)	_
49-32	6255-6263	template	_
49-33	6264-6265	.	_

Text=Then warped GM and WM segments were created.
50-1	6266-6270	Then	_
50-2	6271-6277	warped	_
50-3	6278-6280	GM	_
50-4	6281-6284	and	_
50-5	6285-6287	WM	_
50-6	6288-6296	segments	_
50-7	6297-6301	were	_
50-8	6302-6309	created	_
50-9	6310-6311	.	_

Text=Modulation was applied in order to preserve the volume of a particular tissue within a voxel by multiplying voxel values in the segmented images by the Jacobian determinants derived from the spatial normalization step.
51-1	6312-6322	Modulation	_
51-2	6323-6326	was	_
51-3	6327-6334	applied	_
51-4	6335-6337	in	_
51-5	6338-6343	order	_
51-6	6344-6346	to	_
51-7	6347-6355	preserve	_
51-8	6356-6359	the	_
51-9	6360-6366	volume	_
51-10	6367-6369	of	_
51-11	6370-6371	a	_
51-12	6372-6382	particular	_
51-13	6383-6389	tissue	_
51-14	6390-6396	within	_
51-15	6397-6398	a	_
51-16	6399-6404	voxel	_
51-17	6405-6407	by	_
51-18	6408-6419	multiplying	_
51-19	6420-6425	voxel	_
51-20	6426-6432	values	_
51-21	6433-6435	in	_
51-22	6436-6439	the	_
51-23	6440-6449	segmented	_
51-24	6450-6456	images	_
51-25	6457-6459	by	_
51-26	6460-6463	the	_
51-27	6464-6472	Jacobian	_
51-28	6473-6485	determinants	_
51-29	6486-6493	derived	_
51-30	6494-6498	from	_
51-31	6499-6502	the	_
51-32	6503-6510	spatial	_
51-33	6511-6524	normalization	_
51-34	6525-6529	step	_
51-35	6530-6531	.	_

Text=In effect, the analysis of modulated data tests for regional differences in the absolute amount (volume) of GM/WM.
52-1	6532-6534	In	_
52-2	6535-6541	effect	_
52-3	6542-6543	,	_
52-4	6544-6547	the	_
52-5	6548-6556	analysis	_
52-6	6557-6559	of	_
52-7	6560-6569	modulated	_
52-8	6570-6574	data	_
52-9	6575-6580	tests	_
52-10	6581-6584	for	_
52-11	6585-6593	regional	_
52-12	6594-6605	differences	_
52-13	6606-6608	in	_
52-14	6609-6612	the	_
52-15	6613-6621	absolute	_
52-16	6622-6628	amount	_
52-17	6629-6630	(	_
52-18	6631-6637	volume	_
52-19	6638-6639	)	_
52-20	6640-6642	of	_
52-21	6643-6648	GM/WM	_
52-22	6649-6650	.	_

Text=Images were smoothed with a FWHM (full-width at half maximum) kernel of 8 mm.
53-1	6651-6657	Images	_
53-2	6658-6662	were	_
53-3	6663-6671	smoothed	_
53-4	6672-6676	with	_
53-5	6677-6678	a	_
53-6	6679-6683	FWHM	_
53-7	6684-6685	(	_
53-8	6686-6696	full-width	_
53-9	6697-6699	at	_
53-10	6700-6704	half	_
53-11	6705-6712	maximum	_
53-12	6713-6714	)	_
53-13	6715-6721	kernel	_
53-14	6722-6724	of	_
53-15	6725-6726	8	_
53-16	6727-6729	mm	_
53-17	6730-6731	.	_

Text=Structural equation modelling Analyses were conducted within a structural equation modeling (SEM) framework using MPlus and R. We implemented a two-part latent growth curve model since the AUDIT scores were zero inflated.
54-1	6732-6742	Structural	_
54-2	6743-6751	equation	_
54-3	6752-6761	modelling	_
54-4	6762-6770	Analyses	_
54-5	6771-6775	were	_
54-6	6776-6785	conducted	_
54-7	6786-6792	within	_
54-8	6793-6794	a	_
54-9	6795-6805	structural	_
54-10	6806-6814	equation	_
54-11	6815-6823	modeling	_
54-12	6824-6825	(	_
54-13	6826-6829	SEM	_
54-14	6830-6831	)	_
54-15	6832-6841	framework	_
54-16	6842-6847	using	_
54-17	6848-6853	MPlus	_
54-18	6854-6857	and	_
54-19	6858-6860	R.	_
54-20	6861-6863	We	_
54-21	6864-6875	implemented	_
54-22	6876-6877	a	_
54-23	6878-6886	two-part	_
54-24	6887-6893	latent	_
54-25	6894-6900	growth	_
54-26	6901-6906	curve	_
54-27	6907-6912	model	_
54-28	6913-6918	since	_
54-29	6919-6922	the	_
54-30	6923-6928	AUDIT	_
54-31	6929-6935	scores	_
54-32	6936-6940	were	_
54-33	6941-6945	zero	_
54-34	6946-6954	inflated	_
54-35	6955-6956	.	_

Text=In a two-part latent growth curve model, zeros are valid values with its own meaning and not just proxies for missingness.
55-1	6957-6959	In	_
55-2	6960-6961	a	_
55-3	6962-6970	two-part	_
55-4	6971-6977	latent	_
55-5	6978-6984	growth	_
55-6	6985-6990	curve	_
55-7	6991-6996	model	_
55-8	6997-6998	,	_
55-9	6999-7004	zeros	_
55-10	7005-7008	are	_
55-11	7009-7014	valid	_
55-12	7015-7021	values	_
55-13	7022-7026	with	_
55-14	7027-7030	its	_
55-15	7031-7034	own	_
55-16	7035-7042	meaning	_
55-17	7043-7046	and	_
55-18	7047-7050	not	_
55-19	7051-7055	just	_
55-20	7056-7063	proxies	_
55-21	7064-7067	for	_
55-22	7068-7079	missingness	_
55-23	7080-7081	.	_

Text=Information that is contained by zeros and the specific values of the non-zeros is qualitatively different and might even be differentially influenced by covariates (cf.,).
56-1	7082-7093	Information	_
56-2	7094-7098	that	_
56-3	7099-7101	is	_
56-4	7102-7111	contained	_
56-5	7112-7114	by	_
56-6	7115-7120	zeros	_
56-7	7121-7124	and	_
56-8	7125-7128	the	_
56-9	7129-7137	specific	_
56-10	7138-7144	values	_
56-11	7145-7147	of	_
56-12	7148-7151	the	_
56-13	7152-7161	non-zeros	_
56-14	7162-7164	is	_
56-15	7165-7178	qualitatively	_
56-16	7179-7188	different	_
56-17	7189-7192	and	_
56-18	7193-7198	might	_
56-19	7199-7203	even	_
56-20	7204-7206	be	_
56-21	7207-7221	differentially	_
56-22	7222-7232	influenced	_
56-23	7233-7235	by	_
56-24	7236-7246	covariates	_
56-25	7247-7248	(	_
56-26	7249-7252	cf.	_
56-27	7253-7254	,	_
56-28	7255-7256	)	_
56-29	7257-7258	.	_

Text=In a two-part latent growth curve model, the presence or absence of a behavior and, if present, the manifestation of a specific behavior can be modeled simultaneously in one model.
57-1	7259-7261	In	_
57-2	7262-7263	a	_
57-3	7264-7272	two-part	_
57-4	7273-7279	latent	_
57-5	7280-7286	growth	_
57-6	7287-7292	curve	_
57-7	7293-7298	model	_
57-8	7299-7300	,	_
57-9	7301-7304	the	_
57-10	7305-7313	presence	_
57-11	7314-7316	or	_
57-12	7317-7324	absence	_
57-13	7325-7327	of	_
57-14	7328-7329	a	_
57-15	7330-7338	behavior	_
57-16	7339-7342	and	_
57-17	7343-7344	,	_
57-18	7345-7347	if	_
57-19	7348-7355	present	_
57-20	7356-7357	,	_
57-21	7358-7361	the	_
57-22	7362-7375	manifestation	_
57-23	7376-7378	of	_
57-24	7379-7380	a	_
57-25	7381-7389	specific	_
57-26	7390-7398	behavior	_
57-27	7399-7402	can	_
57-28	7403-7405	be	_
57-29	7406-7413	modeled	_
57-30	7414-7428	simultaneously	_
57-31	7429-7431	in	_
57-32	7432-7435	one	_
57-33	7436-7441	model	_
57-34	7442-7443	.	_

Text=In our study, the original distribution of the alcohol use variable (AUDIT-score) was decomposed into two parts (see Figure 1).
58-1	7444-7446	In	_
58-2	7447-7450	our	_
58-3	7451-7456	study	_
58-4	7457-7458	,	_
58-5	7459-7462	the	_
58-6	7463-7471	original	_
58-7	7472-7484	distribution	_
58-8	7485-7487	of	_
58-9	7488-7491	the	_
58-10	7492-7499	alcohol	_
58-11	7500-7503	use	_
58-12	7504-7512	variable	_
58-13	7513-7514	(	_
58-14	7515-7526	AUDIT-score	_
58-15	7527-7528	)	_
58-16	7529-7532	was	_
58-17	7533-7543	decomposed	_
58-18	7544-7548	into	_
58-19	7549-7552	two	_
58-20	7553-7558	parts	_
58-21	7559-7560	(	_
58-22	7561-7564	see	_
58-23	7565-7571	Figure	_
58-24	7572-7573	1	_
58-25	7574-7575	)	_
58-26	7576-7577	.	_

Text=Then, each was modeled by separate, but correlated, growth functions (see Figure 2).
59-1	7578-7582	Then	_
59-2	7583-7584	,	_
59-3	7585-7589	each	_
59-4	7590-7593	was	_
59-5	7594-7601	modeled	_
59-6	7602-7604	by	_
59-7	7605-7613	separate	_
59-8	7614-7615	,	_
59-9	7616-7619	but	_
59-10	7620-7630	correlated	_
59-11	7631-7632	,	_
59-12	7633-7639	growth	_
59-13	7640-7649	functions	_
59-14	7650-7651	(	_
59-15	7652-7655	see	_
59-16	7656-7662	Figure	_
59-17	7663-7664	2	_
59-18	7665-7666	)	_
59-19	7667-7668	.	_

Text=For the discrete part of the model scores of zero were separated from the rest of the distribution by creating a binary indicator variable that distinguished any positive alcohol use score (=1) from nouse (=0) (lower part of Figure 2).
60-1	7669-7672	For	_
60-2	7673-7676	the	_
60-3	7677-7685	discrete	_
60-4	7686-7690	part	_
60-5	7691-7693	of	_
60-6	7694-7697	the	_
60-7	7698-7703	model	_
60-8	7704-7710	scores	_
60-9	7711-7713	of	_
60-10	7714-7718	zero	_
60-11	7719-7723	were	_
60-12	7724-7733	separated	_
60-13	7734-7738	from	_
60-14	7739-7742	the	_
60-15	7743-7747	rest	_
60-16	7748-7750	of	_
60-17	7751-7754	the	_
60-18	7755-7767	distribution	_
60-19	7768-7770	by	_
60-20	7771-7779	creating	_
60-21	7780-7781	a	_
60-22	7782-7788	binary	_
60-23	7789-7798	indicator	_
60-24	7799-7807	variable	_
60-25	7808-7812	that	_
60-26	7813-7826	distinguished	_
60-27	7827-7830	any	_
60-28	7831-7839	positive	_
60-29	7840-7847	alcohol	_
60-30	7848-7851	use	_
60-31	7852-7857	score	_
60-32	7858-7859	(	_
60-33	7860-7862	=1	_
60-34	7863-7864	)	_
60-35	7865-7869	from	_
60-36	7870-7875	nouse	_
60-37	7876-7877	(	_
60-38	7878-7880	=0	_
60-39	7881-7882	)	_
60-40	7883-7884	(	_
60-41	7885-7890	lower	_
60-42	7891-7895	part	_
60-43	7896-7898	of	_
60-44	7899-7905	Figure	_
60-45	7906-7907	2	_
60-46	7908-7909	)	_
60-47	7910-7911	.	_

Text=For the continuous part of the model, the continuous indicator variables representing the AUDIT score, given that it was above zero, were used (upper part of Figure 2).
61-1	7912-7915	For	_
61-2	7916-7919	the	_
61-3	7920-7930	continuous	_
61-4	7931-7935	part	_
61-5	7936-7938	of	_
61-6	7939-7942	the	_
61-7	7943-7948	model	_
61-8	7949-7950	,	_
61-9	7951-7954	the	_
61-10	7955-7965	continuous	_
61-11	7966-7975	indicator	_
61-12	7976-7985	variables	_
61-13	7986-7998	representing	_
61-14	7999-8002	the	_
61-15	8003-8008	AUDIT	_
61-16	8009-8014	score	_
61-17	8015-8016	,	_
61-18	8017-8022	given	_
61-19	8023-8027	that	_
61-20	8028-8030	it	_
61-21	8031-8034	was	_
61-22	8035-8040	above	_
61-23	8041-8045	zero	_
61-24	8046-8047	,	_
61-25	8048-8052	were	_
61-26	8053-8057	used	_
61-27	8058-8059	(	_
61-28	8060-8065	upper	_
61-29	8066-8070	part	_
61-30	8071-8073	of	_
61-31	8074-8080	Figure	_
61-32	8081-8082	2	_
61-33	8083-8084	)	_
61-34	8085-8086	.	_

Text=In this latter part of the model, substance non-use within each time point was treated as missing data, following standard assumptions of data missing at random (MAR).
62-1	8087-8089	In	_
62-2	8090-8094	this	_
62-3	8095-8101	latter	_
62-4	8102-8106	part	_
62-5	8107-8109	of	_
62-6	8110-8113	the	_
62-7	8114-8119	model	_
62-8	8120-8121	,	_
62-9	8122-8131	substance	_
62-10	8132-8139	non-use	_
62-11	8140-8146	within	_
62-12	8147-8151	each	_
62-13	8152-8156	time	_
62-14	8157-8162	point	_
62-15	8163-8166	was	_
62-16	8167-8174	treated	_
62-17	8175-8177	as	_
62-18	8178-8185	missing	_
62-19	8186-8190	data	_
62-20	8191-8192	,	_
62-21	8193-8202	following	_
62-22	8203-8211	standard	_
62-23	8212-8223	assumptions	_
62-24	8224-8226	of	_
62-25	8227-8231	data	_
62-26	8232-8239	missing	_
62-27	8240-8242	at	_
62-28	8243-8249	random	_
62-29	8250-8251	(	_
62-30	8252-8255	MAR	_
62-31	8256-8257	)	_
62-32	8258-8259	.	_

Text=In that way participants who did not drink alcohol throughout the study contributed little information to the growth parameter estimates, but all information to alcohol use was used to estimate the growth parameters.
63-1	8260-8262	In	_
63-2	8263-8267	that	_
63-3	8268-8271	way	_
63-4	8272-8284	participants	_
63-5	8285-8288	who	_
63-6	8289-8292	did	_
63-7	8293-8296	not	_
63-8	8297-8302	drink	_
63-9	8303-8310	alcohol	_
63-10	8311-8321	throughout	_
63-11	8322-8325	the	_
63-12	8326-8331	study	_
63-13	8332-8343	contributed	_
63-14	8344-8350	little	_
63-15	8351-8362	information	_
63-16	8363-8365	to	_
63-17	8366-8369	the	_
63-18	8370-8376	growth	_
63-19	8377-8386	parameter	_
63-20	8387-8396	estimates	_
63-21	8397-8398	,	_
63-22	8399-8402	but	_
63-23	8403-8406	all	_
63-24	8407-8418	information	_
63-25	8419-8421	to	_
63-26	8422-8429	alcohol	_
63-27	8430-8433	use	_
63-28	8434-8437	was	_
63-29	8438-8442	used	_
63-30	8443-8445	to	_
63-31	8446-8454	estimate	_
63-32	8455-8458	the	_
63-33	8459-8465	growth	_
63-34	8466-8476	parameters	_
63-35	8477-8478	.	_

Text=We used Maximum Likelihood estimator for our analyses.
64-1	8479-8481	We	_
64-2	8482-8486	used	_
64-3	8487-8494	Maximum	_
64-4	8495-8505	Likelihood	_
64-5	8506-8515	estimator	_
64-6	8516-8519	for	_
64-7	8520-8523	our	_
64-8	8524-8532	analyses	_
64-9	8533-8534	.	_

Text=We controlled for the effects of age at baseline, sex, total brain volume (TBV) and site (by dummy coding eight of all nine neuroimaging sites, for simplicity we represent this by only one manifest variable in Figure 2) onto the slope of the continuous part of the growth model.
65-1	8535-8537	We	_
65-2	8538-8548	controlled	_
65-3	8549-8552	for	_
65-4	8553-8556	the	_
65-5	8557-8564	effects	_
65-6	8565-8567	of	_
65-7	8568-8571	age	_
65-8	8572-8574	at	_
65-9	8575-8583	baseline	_
65-10	8584-8585	,	_
65-11	8586-8589	sex	_
65-12	8590-8591	,	_
65-13	8592-8597	total	_
65-14	8598-8603	brain	_
65-15	8604-8610	volume	_
65-16	8611-8612	(	_
65-17	8613-8616	TBV	_
65-18	8617-8618	)	_
65-19	8619-8622	and	_
65-20	8623-8627	site	_
65-21	8628-8629	(	_
65-22	8630-8632	by	_
65-23	8633-8638	dummy	_
65-24	8639-8645	coding	_
65-25	8646-8651	eight	_
65-26	8652-8654	of	_
65-27	8655-8658	all	_
65-28	8659-8663	nine	_
65-29	8664-8676	neuroimaging	_
65-30	8677-8682	sites	_
65-31	8683-8684	,	_
65-32	8685-8688	for	_
65-33	8689-8699	simplicity	_
65-34	8700-8702	we	_
65-35	8703-8712	represent	_
65-36	8713-8717	this	_
65-37	8718-8720	by	_
65-38	8721-8725	only	_
65-39	8726-8729	one	_
65-40	8730-8738	manifest	_
65-41	8739-8747	variable	_
65-42	8748-8750	in	_
65-43	8751-8757	Figure	_
65-44	8758-8759	2	_
65-45	8760-8761	)	_
65-46	8762-8766	onto	_
65-47	8767-8770	the	_
65-48	8771-8776	slope	_
65-49	8777-8779	of	_
65-50	8780-8783	the	_
65-51	8784-8794	continuous	_
65-52	8795-8799	part	_
65-53	8800-8802	of	_
65-54	8803-8806	the	_
65-55	8807-8813	growth	_
65-56	8814-8819	model	_
65-57	8820-8821	.	_

Text=As criteria for model fit we report Root Mean Square Error of Approximation (RMSEA), Comparative Fit Index (CFI), and Standardized Root Mean Square Residual (SRMR).
66-1	8822-8824	As	_
66-2	8825-8833	criteria	_
66-3	8834-8837	for	_
66-4	8838-8843	model	_
66-5	8844-8847	fit	_
66-6	8848-8850	we	_
66-7	8851-8857	report	_
66-8	8858-8862	Root	_
66-9	8863-8867	Mean	_
66-10	8868-8874	Square	_
66-11	8875-8880	Error	_
66-12	8881-8883	of	_
66-13	8884-8897	Approximation	_
66-14	8898-8899	(	_
66-15	8900-8905	RMSEA	_
66-16	8906-8907	)	_
66-17	8908-8909	,	_
66-18	8910-8921	Comparative	_
66-19	8922-8925	Fit	_
66-20	8926-8931	Index	_
66-21	8932-8933	(	_
66-22	8934-8937	CFI	_
66-23	8938-8939	)	_
66-24	8940-8941	,	_
66-25	8942-8945	and	_
66-26	8946-8958	Standardized	_
66-27	8959-8963	Root	_
66-28	8964-8968	Mean	_
66-29	8969-8975	Square	_
66-30	8976-8984	Residual	_
66-31	8985-8986	(	_
66-32	8987-8991	SRMR	_
66-33	8992-8993	)	_
66-34	8994-8995	.	_

Text=Values of the CFI above 0.90 denote a well-fitting model, whereas for the RMSEA and the SRMR values less than 0.08 may be interpreted as acceptable model-fit.
67-1	8996-9002	Values	_
67-2	9003-9005	of	_
67-3	9006-9009	the	_
67-4	9010-9013	CFI	_
67-5	9014-9019	above	_
67-6	9020-9024	0.90	_
67-7	9025-9031	denote	_
67-8	9032-9033	a	_
67-9	9034-9046	well-fitting	_
67-10	9047-9052	model	_
67-11	9053-9054	,	_
67-12	9055-9062	whereas	_
67-13	9063-9066	for	_
67-14	9067-9070	the	_
67-15	9071-9076	RMSEA	_
67-16	9077-9080	and	_
67-17	9081-9084	the	_
67-18	9085-9089	SRMR	_
67-19	9090-9096	values	_
67-20	9097-9101	less	_
67-21	9102-9106	than	_
67-22	9107-9111	0.08	_
67-23	9112-9115	may	_
67-24	9116-9118	be	_
67-25	9119-9130	interpreted	_
67-26	9131-9133	as	_
67-27	9134-9144	acceptable	_
67-28	9145-9154	model-fit	_
67-29	9155-9156	.	_

Text=Since our main interest was, which voxels of the brain from grey matter and white matter maps at age 14 years predict the continuous slope representing the increase of alcohol drinking over time, the final SEM models were conducted including a brain variable.
68-1	9157-9162	Since	_
68-2	9163-9166	our	_
68-3	9167-9171	main	_
68-4	9172-9180	interest	_
68-5	9181-9184	was	_
68-6	9185-9186	,	_
68-7	9187-9192	which	_
68-8	9193-9199	voxels	_
68-9	9200-9202	of	_
68-10	9203-9206	the	_
68-11	9207-9212	brain	_
68-12	9213-9217	from	_
68-13	9218-9222	grey	_
68-14	9223-9229	matter	_
68-15	9230-9233	and	_
68-16	9234-9239	white	_
68-17	9240-9246	matter	_
68-18	9247-9251	maps	_
68-19	9252-9254	at	_
68-20	9255-9258	age	_
68-21	9259-9261	14	_
68-22	9262-9267	years	_
68-23	9268-9275	predict	_
68-24	9276-9279	the	_
68-25	9280-9290	continuous	_
68-26	9291-9296	slope	_
68-27	9297-9309	representing	_
68-28	9310-9313	the	_
68-29	9314-9322	increase	_
68-30	9323-9325	of	_
68-31	9326-9333	alcohol	_
68-32	9334-9342	drinking	_
68-33	9343-9347	over	_
68-34	9348-9352	time	_
68-35	9353-9354	,	_
68-36	9355-9358	the	_
68-37	9359-9364	final	_
68-38	9365-9368	SEM	_
68-39	9369-9375	models	_
68-40	9376-9380	were	_
68-41	9381-9390	conducted	_
68-42	9391-9400	including	_
68-43	9401-9402	a	_
68-44	9403-9408	brain	_
68-45	9409-9417	variable	_
68-46	9418-9419	.	_

Text=For this purpose, we ran separate two-part growth mixture models for each and every voxel of the brain and repeated this analyses for the grey and white matter maps separately.
69-1	9420-9423	For	_
69-2	9424-9428	this	_
69-3	9429-9436	purpose	_
69-4	9437-9438	,	_
69-5	9439-9441	we	_
69-6	9442-9445	ran	_
69-7	9446-9454	separate	_
69-8	9455-9463	two-part	_
69-9	9464-9470	growth	_
69-10	9471-9478	mixture	_
69-11	9479-9485	models	_
69-12	9486-9489	for	_
69-13	9490-9494	each	_
69-14	9495-9498	and	_
69-15	9499-9504	every	_
69-16	9505-9510	voxel	_
69-17	9511-9513	of	_
69-18	9514-9517	the	_
69-19	9518-9523	brain	_
69-20	9524-9527	and	_
69-21	9528-9536	repeated	_
69-22	9537-9541	this	_
69-23	9542-9550	analyses	_
69-24	9551-9554	for	_
69-25	9555-9558	the	_
69-26	9559-9563	grey	_
69-27	9564-9567	and	_
69-28	9568-9573	white	_
69-29	9574-9580	matter	_
69-30	9581-9585	maps	_
69-31	9586-9596	separately	_
69-32	9597-9598	.	_

Text=This approach is exploratory as no specific areas of the brain are extracted (as would be the case in the more traditional analyses of ROI).
70-1	9599-9603	This	_
70-2	9604-9612	approach	_
70-3	9613-9615	is	_
70-4	9616-9627	exploratory	_
70-5	9628-9630	as	_
70-6	9631-9633	no	_
70-7	9634-9642	specific	_
70-8	9643-9648	areas	_
70-9	9649-9651	of	_
70-10	9652-9655	the	_
70-11	9656-9661	brain	_
70-12	9662-9665	are	_
70-13	9666-9675	extracted	_
70-14	9676-9677	(	_
70-15	9678-9680	as	_
70-16	9681-9686	would	_
70-17	9687-9689	be	_
70-18	9690-9693	the	_
70-19	9694-9698	case	_
70-20	9699-9701	in	_
70-21	9702-9705	the	_
70-22	9706-9710	more	_
70-23	9711-9722	traditional	_
70-24	9723-9731	analyses	_
70-25	9732-9734	of	_
70-26	9735-9738	ROI	_
70-27	9739-9740	)	_
70-28	9741-9742	.	_

Text=While it bears the risk of inflated type-II-errors, it also enables the investigation of links between brain structures and behavior that have not been strictly established yet.
71-1	9743-9748	While	_
71-2	9749-9751	it	_
71-3	9752-9757	bears	_
71-4	9758-9761	the	_
71-5	9762-9766	risk	_
71-6	9767-9769	of	_
71-7	9770-9778	inflated	_
71-8	9779-9793	type-II-errors	_
71-9	9794-9795	,	_
71-10	9796-9798	it	_
71-11	9799-9803	also	_
71-12	9804-9811	enables	_
71-13	9812-9815	the	_
71-14	9816-9829	investigation	_
71-15	9830-9832	of	_
71-16	9833-9838	links	_
71-17	9839-9846	between	_
71-18	9847-9852	brain	_
71-19	9853-9863	structures	_
71-20	9864-9867	and	_
71-21	9868-9876	behavior	_
71-22	9877-9881	that	_
71-23	9882-9886	have	_
71-24	9887-9890	not	_
71-25	9891-9895	been	_
71-26	9896-9904	strictly	_
71-27	9905-9916	established	_
71-28	9917-9920	yet	_
71-29	9921-9922	.	_

Text=For each SEM that was generated with a specific voxel as covariate, we plotted the estimate/p-value of the regression path from brain to the slope back into the brain, to be able to plot the resulting image using R (the scripts can be obtained from the first author, more flexible functions that may be helpful in conducting similar analyses can be found in the 'neuropointillist' R package, https: //github.com/IBIC/neuropointillist,).
72-1	9923-9926	For	_
72-2	9927-9931	each	_
72-3	9932-9935	SEM	_
72-4	9936-9940	that	_
72-5	9941-9944	was	_
72-6	9945-9954	generated	_
72-7	9955-9959	with	_
72-8	9960-9961	a	_
72-9	9962-9970	specific	_
72-10	9971-9976	voxel	_
72-11	9977-9979	as	_
72-12	9980-9989	covariate	_
72-13	9990-9991	,	_
72-14	9992-9994	we	_
72-15	9995-10002	plotted	_
72-16	10003-10006	the	_
72-17	10007-10023	estimate/p-value	_
72-18	10024-10026	of	_
72-19	10027-10030	the	_
72-20	10031-10041	regression	_
72-21	10042-10046	path	_
72-22	10047-10051	from	_
72-23	10052-10057	brain	_
72-24	10058-10060	to	_
72-25	10061-10064	the	_
72-26	10065-10070	slope	_
72-27	10071-10075	back	_
72-28	10076-10080	into	_
72-29	10081-10084	the	_
72-30	10085-10090	brain	_
72-31	10091-10092	,	_
72-32	10093-10095	to	_
72-33	10096-10098	be	_
72-34	10099-10103	able	_
72-35	10104-10106	to	_
72-36	10107-10111	plot	_
72-37	10112-10115	the	_
72-38	10116-10125	resulting	_
72-39	10126-10131	image	_
72-40	10132-10137	using	_
72-41	10138-10139	R	_
72-42	10140-10141	(	_
72-43	10142-10145	the	_
72-44	10146-10153	scripts	_
72-45	10154-10157	can	_
72-46	10158-10160	be	_
72-47	10161-10169	obtained	_
72-48	10170-10174	from	_
72-49	10175-10178	the	_
72-50	10179-10184	first	_
72-51	10185-10191	author	_
72-52	10192-10193	,	_
72-53	10194-10198	more	_
72-54	10199-10207	flexible	_
72-55	10208-10217	functions	_
72-56	10218-10222	that	_
72-57	10223-10226	may	_
72-58	10227-10229	be	_
72-59	10230-10237	helpful	_
72-60	10238-10240	in	_
72-61	10241-10251	conducting	_
72-62	10252-10259	similar	_
72-63	10260-10268	analyses	_
72-64	10269-10272	can	_
72-65	10273-10275	be	_
72-66	10276-10281	found	_
72-67	10282-10284	in	_
72-68	10285-10288	the	_
72-69	10289-10306	'neuropointillist	_
72-70	10307-10308	'	_
72-71	10309-10310	R	_
72-72	10311-10318	package	_
72-73	10319-10320	,	_
72-74	10321-10326	https	_
72-75	10327-10328	:	_
72-76	10329-10363	//github.com/IBIC/neuropointillist	_
72-77	10364-10365	,	_
72-78	10366-10367	)	_
72-79	10368-10369	.	_

Text=This approach is not limited to growth curve models but can easily be extended to all types of models that can be implemented in MPlus).
73-1	10370-10374	This	_
73-2	10375-10383	approach	_
73-3	10384-10386	is	_
73-4	10387-10390	not	_
73-5	10391-10398	limited	_
73-6	10399-10401	to	_
73-7	10402-10408	growth	_
73-8	10409-10414	curve	_
73-9	10415-10421	models	_
73-10	10422-10425	but	_
73-11	10426-10429	can	_
73-12	10430-10436	easily	_
73-13	10437-10439	be	_
73-14	10440-10448	extended	_
73-15	10449-10451	to	_
73-16	10452-10455	all	_
73-17	10456-10461	types	_
73-18	10462-10464	of	_
73-19	10465-10471	models	_
73-20	10472-10476	that	_
73-21	10477-10480	can	_
73-22	10481-10483	be	_
73-23	10484-10495	implemented	_
73-24	10496-10498	in	_
73-25	10499-10504	MPlus	_
73-26	10505-10506	)	_
73-27	10507-10508	.	_

Text=Finally, we thresholded the resulting maps with a threshold of p <0.001 and a cluster threshold of k> 100.
74-1	10509-10516	Finally	_
74-2	10517-10518	,	_
74-3	10519-10521	we	_
74-4	10522-10533	thresholded	_
74-5	10534-10537	the	_
74-6	10538-10547	resulting	_
74-7	10548-10552	maps	_
74-8	10553-10557	with	_
74-9	10558-10559	a	_
74-10	10560-10569	threshold	_
74-11	10570-10572	of	_
74-12	10573-10574	p	_
74-13	10575-10576	<	_
74-14	10577-10582	0.001	_
74-15	10583-10586	and	_
74-16	10587-10588	a	_
74-17	10589-10596	cluster	_
74-18	10597-10606	threshold	_
74-19	10607-10609	of	_
74-20	10610-10611	k	_
74-21	10612-10613	>	_
74-22	10614-10617	100	_
74-23	10618-10619	.	_

Text=We repeated the same analyses while predicting the discrete slope from voxels of the grey and white matter maps, although our main interest was on brain-wise predictors of the slope derived from the continuous part of the model.
75-1	10620-10622	We	_
75-2	10623-10631	repeated	_
75-3	10632-10635	the	_
75-4	10636-10640	same	_
75-5	10641-10649	analyses	_
75-6	10650-10655	while	_
75-7	10656-10666	predicting	_
75-8	10667-10670	the	_
75-9	10671-10679	discrete	_
75-10	10680-10685	slope	_
75-11	10686-10690	from	_
75-12	10691-10697	voxels	_
75-13	10698-10700	of	_
75-14	10701-10704	the	_
75-15	10705-10709	grey	_
75-16	10710-10713	and	_
75-17	10714-10719	white	_
75-18	10720-10726	matter	_
75-19	10727-10731	maps	_
75-20	10732-10733	,	_
75-21	10734-10742	although	_
75-22	10743-10746	our	_
75-23	10747-10751	main	_
75-24	10752-10760	interest	_
75-25	10761-10764	was	_
75-26	10765-10767	on	_
75-27	10768-10778	brain-wise	_
75-28	10779-10789	predictors	_
75-29	10790-10792	of	_
75-30	10793-10796	the	_
75-31	10797-10802	slope	_
75-32	10803-10810	derived	_
75-33	10811-10815	from	_
75-34	10816-10819	the	_
75-35	10820-10830	continuous	_
75-36	10831-10835	part	_
75-37	10836-10838	of	_
75-38	10839-10842	the	_
75-39	10843-10848	model	_
75-40	10849-10850	.	_

